Harbor:Creatinine screening prior to IV contrast: Difference between revisions
Line 6: Line 6:


#  They are '''<60 years old''' AND do NOT have
#  They are '''<60 years old''' AND do NOT have
## history of kidney failure or transplant,
## history of kidney failure or transplant
## family history of kidney failure,
## family history of kidney failure
## diabetes, hypertension,
## diabetes, hypertension
## collagen vascular disease (eg, SLE, scleroderma, rheumatoid arthritis),
## collagen vascular disease (eg, SLE, scleroderma, rheumatoid arthritis)
## paraproteinemia syndrome (eg, myeloma), or
## paraproteinemia syndrome (eg, myeloma)
## recent use of nephrotoxic medication (eg, aminoglycosides) as determined by the attending emergency physician.
## recent use of nephrotoxic medication (eg, aminoglycosides)
#Emergency department patients do not require a creatinine level to be checked prior to the administration onv contrast if the study is immediately necessary to prevent life-threatening decompensation or delay in emergent treatment as determined by the attending emergency physician.
#If the study is immediately necessary to prevent life-threatening decompensation or delay in emergent treatment


==Source==
==Source==
*American College of Radiology Manual on Contrast Administration
*American College of Radiology Manual on Contrast Administration
*Harbor-UCLA Medical Center Policy, "Emergency Department Creatinine Screening Guidelines for Radiographic Evaluations"
*Harbor-UCLA Medical Center Policy, "Emergency Department Creatinine Screening Guidelines for Radiographic Evaluations"

Revision as of 00:08, 1 September 2011

Background

To expedite the appropriate use of creatinine screening in ED patients requiring IV contrast for CT or other radiographic evaluation

Guideline

ED patients do NOT require Cr measurement prior to IV contrast if:

  1. They are <60 years old AND do NOT have
    1. history of kidney failure or transplant
    2. family history of kidney failure
    3. diabetes, hypertension
    4. collagen vascular disease (eg, SLE, scleroderma, rheumatoid arthritis)
    5. paraproteinemia syndrome (eg, myeloma)
    6. recent use of nephrotoxic medication (eg, aminoglycosides)
  2. If the study is immediately necessary to prevent life-threatening decompensation or delay in emergent treatment

Source

  • American College of Radiology Manual on Contrast Administration
  • Harbor-UCLA Medical Center Policy, "Emergency Department Creatinine Screening Guidelines for Radiographic Evaluations"
Retrieved from "https://www.wikem.org/w/index.php?title=Harbor:Creatinine_screening_prior_to_IV_contrast&oldid=5517"